A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.

NCT01206764 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
143
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals